Skip to main content

Affymetrix Eureka Genotyping Solution

Affymetrix has launched Eureka Genotyping Solution a low-cost, low-plex genotyping by sequencing solution. The company is also introducing two new array configurations for the Axiom genotyping platform. The Eureka Genotyping Solution delivers high-throughput sample processing with low cost per sample enabled by an innovative multiplexed combination of allele and sample-specific barcodes which support high sample plexing on a sequencer while delivering high-quality SNP analysis, said the company. The new array configurations for Axiom genotyping expand its utility. The 24-sample configuration on the high-density Axiom 96 platform can interrogate upward of 800,000 markers while the 96-sample configuration on the Axiom 384 HT platform can assay about 50,000 genetic variants. 

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.